Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36201 - 36225 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Edetic acid	Approved Investigational Vet Approved	SLC30A10	55532	upregulated	Edetic Acid results in increased expression of SLC30A10 mRNA	1q41	A22490
Efavirenz	Approved Investigational	ADIPOQ	9370	downregulated	efavirenz results in decreased expression of ADIPOQ mRNA	3q27.3	A22491
Efavirenz	Approved Investigational	BCL2L11	10018	upregulated	efavirenz metabolite results in increased expression of BCL2L11 mRNA	2q13	A22492
Efavirenz	Approved Investigational	BCL2L11	10018	upregulated	efavirenz results in increased expression of BCL2L11 mRNA	2q13	A22492
Efavirenz	Approved Investigational	CEBPA	1050	downregulated	efavirenz results in decreased expression of CEBPA mRNA	19q13.11	A22491
Efavirenz	Approved Investigational	CYP2B6	1555	upregulated	[efavirenz results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA	19q13.2	A21544
Efavirenz	Approved Investigational	CYP2B6	1555	upregulated	[efavirenz results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA	19q13.2	A21544
Efavirenz	Approved Investigational	CYP3A4	1576	upregulated	efavirenz results in increased expression of CYP3A4 mRNA	7q22.1	A20983
Efavirenz	Approved Investigational	LEP	3952	downregulated	efavirenz results in decreased expression of LEP mRNA	7q32.1	A22491
Efavirenz	Approved Investigational	LPL	4023	downregulated	efavirenz results in decreased expression of LPL mRNA	8p21.3	A22491
Efavirenz	Approved Investigational	PPARG	5468	downregulated	efavirenz results in decreased expression of PPARG mRNA	3p25.2	A22491
Efavirenz	Approved Investigational	SREBF1	6720	downregulated	efavirenz results in decreased expression of SREBF1 mRNA	17p11.2	A22491
Efavirenz	Approved Investigational	TG	7038	upregulated	efavirenz results in increased expression of TG mRNA	8q24.22	A22493
Efavirenz	Approved Investigational	TPO	7173	upregulated	efavirenz results in increased expression of TPO mRNA	2p25.3	A22493
Efavirenz	Approved Investigational	TSHR	7253	upregulated	efavirenz results in increased expression of TSHR mRNA	14q24-q31	A22493
Icosapent	Approved Investigational Nutraceutical	ABCA1	19	downregulated	Eicosapentaenoic Acid results in decreased expression of ABCA1 mRNA	9q31.1	A20507
Icosapent	Approved Investigational Nutraceutical	ABCG1	9619	downregulated	Eicosapentaenoic Acid results in decreased expression of ABCG1 mRNA	21q22.3	A20507
Icosapent	Approved Investigational Nutraceutical	CYBA	1535	downregulated	Eicosapentaenoic Acid results in decreased expression of CYBA mRNA	16q24.2	A11515
Icosapent	Approved Investigational Nutraceutical	GCLC	2729	upregulated	Eicosapentaenoic Acid results in increased expression of GCLC mRNA	6p12.1	A20608
Icosapent	Approved Investigational Nutraceutical	GSTM2	2946	upregulated	Eicosapentaenoic Acid results in increased expression of GSTM2 mRNA	1p13.3	A22494
Icosapent	Approved Investigational Nutraceutical	HMOX1	3162	upregulated	Eicosapentaenoic Acid results in increased expression of HMOX1 mRNA	22q12.3	A20608 A22494
Icosapent	Approved Investigational Nutraceutical	LEP	3952	downregulated	Eicosapentaenoic Acid results in decreased expression of LEP mRNA	7q32.1	A19957
Icosapent	Approved Investigational Nutraceutical	MMP10	4319	downregulated	Eicosapentaenoic Acid results in decreased expression of MMP10 mRNA	11q22.2	A22495
Icosapent	Approved Investigational Nutraceutical	NFE2L2	4780	upregulated	Eicosapentaenoic Acid results in increased expression of NFE2L2 mRNA	2q31.2	A22494
Icosapent	Approved Investigational Nutraceutical	NQO1	1728	upregulated	Eicosapentaenoic Acid results in increased expression of NQO1 mRNA	16q22.1	A22494

Displaying entries 36201 - 36225 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability